The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population

NCT02973464 · clinicaltrials.gov ↗

UNKNOWN

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Recipients

Interventions

DRUG: Valganciclovir
DRUG: Ganciclovir

Sponsor

First Affiliated Hospital Xi'an Jiaotong University